Stemness, inflammation and epithelial–mesenchymal transition in colorectal carcinoma: The intricate network

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)
2 Downloads (Pure)


In global cancer statistics, colorectal carcinoma (CRC) ranks third by incidence and second by mortality, causing 10.0% of new cancer cases and 9.4% of oncological deaths worldwide. Despite the development of screening programs and preventive measures, there are still high numbers of advanced cases. Multiple problems compromise the treatment of metastatic colorectal cancer, one of these being cancer stem cells—a minor fraction of pluripotent, self-renewing malignant cells capable of maintaining steady, low proliferation and exhibiting an intriguing arsenal of treatment resistance mechanisms. Currently, there is an increasing body of evidence for intricate associations between inflammation, epithelial–mesenchymal transition and cancer stem cells. In this review, we focus on inflammation and its role in CRC stemness development through epithelial–mesenchymal transition.

Original languageEnglish
Article number12891
Number of pages15
JournalInternational Journal of Molecular Sciences
Issue number23
Publication statusPublished - 29 Nov 2021


  • Colorectal cancer
  • Epithelial–mesenchymal transition
  • Immuno-histochemistry
  • Inflammation
  • Stem cells

Field of Science*

  • 3.2 Clinical medicine
  • 3.1 Basic medicine

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database


Dive into the research topics of 'Stemness, inflammation and epithelial–mesenchymal transition in colorectal carcinoma: The intricate network'. Together they form a unique fingerprint.

Cite this